Position in LLY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$15,987,203
+$5,750,164 QoQ
Shares Held
13,329
+19.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.18%
of 13F equity value
Holder Rank
#1,006
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 53%
Shared 0%
None 47%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NICOLET BANKSHARES INC holds $53,996,275 across 11 Drug Manufacturers - General names. LLY ranks #1 (29.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
13,329 | $15,987,203 | |
| 2 | JNJ |
Johnson & Johnson
|
47,859 | $12,154,749 | |
| 3 | ABBV |
AbbVie Inc.
|
42,391 | $10,667,269 | |
| 4 | MRK |
Merck & Co., Inc.
|
28,130 | $3,614,705 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
50,571 | $2,913,900 | |
| 6 | PFE |
Pfizer Inc
|
109,634 | $2,639,986 | |
| 7 | GSK |
GSK plc
|
44,504 | $2,332,898 | |
| 8 | BIIB |
Biogen Inc.
|
6,476 | $1,399,203 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,987,203 | 13,329 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $10,237,039 | 11,130 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,414,279 | 1,316 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $1,051,414 | 1,378 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,125,641 | 1,444 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,014,217 | 1,228 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $951,876 | 1,233 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,110,968 | 1,254 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,304,652 | 1,441 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,148,268 | 1,476 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $847,565 | 1,454 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $854,036 | 1,590 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $766,313 | 1,634 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $563,895 | 1,642 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $667,292 | 1,824 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $1,185,724 | 3,667 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,376,356 | 4,245 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $1,662,091 | 5,804 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $1,577,768 | 5,712 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $1,264,998 | 5,475 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $1,108,352 | 4,829 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $858,251 | 4,594 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $757,416 | 4,486 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $419,784 | 2,836 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $465,614 | 2,836 | Shares | Defined | 2020-07-22 | |
| 2020-03-31 | $393,409 | 2,836 | Shares | Defined | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||